
Immunoprecipitation Market by Product (Accessories, Beads, Kits), Type (Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation), End-User - Global Forecast 2024-2030
Description
Immunoprecipitation Market by Product (Accessories, Beads, Kits), Type (Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation), End-User - Global Forecast 2024-2030
The Immunoprecipitation Market size was estimated at USD 1.36 billion in 2023 and expected to reach USD 1.64 billion in 2024, at a CAGR 20.78% to reach USD 5.13 billion by 2030.
Global Immunoprecipitation Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Immunoprecipitation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunoprecipitation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Immunoprecipitation Market, highlighting leading vendors and their innovative profiles. These include Abbkine Scientific Co., Ltd, Abcam PLC, Axil Scientific Pte Ltd., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer Inc., Cell Signaling Technology, Inc., Creative Biomart Inc., Cytoskeleton, Inc., EpiGentek Group Inc., Geno Technology, Inc., LifeSpan BioSciences, Inc., MyJoVE Corporation, Proteintech Group, Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Immunoprecipitation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Accessories
Primary Antibodies
Secondary Antibodies
Beads
Agarose Beads
Buffers
Magnetic Beads
Kits
Reagents
Type
Chromatin Immunoprecipitation
Co-Immunoprecipitation
Individual Immunoprecipitation
RNA Immunoprecipitation
End-User
Academic & Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Immunoprecipitation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunoprecipitation Market?
3. What are the technology trends and regulatory frameworks in the Immunoprecipitation Market?
4. What is the market share of the leading vendors in the Immunoprecipitation Market?
5. Which modes and strategic moves are suitable for entering the Immunoprecipitation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
181 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Immunoprecipitation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing applications of immunoprecipitation testing in central nervous disorders
- 5.1.1.2. Rise in the number of life science experiments and research activities
- 5.1.1.3. Development of improved protocols for chromatin immunoprecipitation
- 5.1.2. Restraints
- 5.1.2.1. Presence of alternative technologies for protein purification
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in immunoprecipitation techniques
- 5.1.3.2. Rising investments by governments and various industries
- 5.1.4. Challenges
- 5.1.4.1. Issues related to quality over research antibodies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Immunoprecipitation Market, by Product
- 6.1. Introduction
- 6.2. Accessories
- 6.3.1. Primary Antibodies
- 6.3.2. Secondary Antibodies
- 6.3. Beads
- 6.4.1. Agarose Beads
- 6.4.2. Buffers
- 6.4.3. Magnetic Beads
- 6.4. Kits
- 6.5. Reagents
- 7. Immunoprecipitation Market, by Type
- 7.1. Introduction
- 7.2. Chromatin Immunoprecipitation
- 7.3. Co-Immunoprecipitation
- 7.4. Individual Immunoprecipitation
- 7.5. RNA Immunoprecipitation
- 8. Immunoprecipitation Market, by End-User
- 8.1. Introduction
- 8.2. Academic & Research Institutes
- 8.3. Contract Research Organizations
- 8.4. Pharmaceutical & Biotechnology Companies
- 9. Americas Immunoprecipitation Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Immunoprecipitation Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.
- 10. South Korea
- 10.
- 11. Taiwan
- 10.
- 12. Thailand
- 10.
- 13. Vietnam
- 11. Europe, Middle East & Africa Immunoprecipitation Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.
- 10. Nigeria
- 11.
- 11. Norway
- 11.
- 12. Poland
- 11.
- 13. Qatar
- 11.
- 14. Russia
- 11.
- 15. Saudi Arabia
- 11.
- 16. South Africa
- 11.
- 17. Spain
- 11.
- 18. Sweden
- 11.
- 19. Switzerland
- 11.
- 20. Turkey
- 11.
- 21. United Arab Emirates
- 11.
- 22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbkine Scientific Co., Ltd
- 13.1.2. Abcam PLC
- 13.1.3. Axil Scientific Pte Ltd.
- 13.1.4. Bio-Rad Laboratories, Inc.
- 13.1.5. BioLegend, Inc. by PerkinElmer Inc.
- 13.1.6. Cell Signaling Technology, Inc.
- 13.1.7. Creative Biomart Inc.
- 13.1.8. Cytoskeleton, Inc.
- 13.1.9. EpiGentek Group Inc.
- 13.1.
- 10. Geno Technology, Inc.
- 13.1.
- 11. LifeSpan BioSciences, Inc.
- 13.1.
- 12. MyJoVE Corporation
- 13.1.
- 13. Proteintech Group, Inc.
- 13.1.
- 14. Sino Biological Inc.
- 13.1.
- 15. Thermo Fisher Scientific Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
- FIGURE 2. IMMUNOPRECIPITATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. IMMUNOPRECIPITATION MARKET DYNAMICS
- FIGURE 7. IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.